{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:15:21Z","timestamp":1768745721421,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.drugalcdep.2012.10.001","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T10:01:11Z","timestamp":1351936871000},"page":"125-136","source":"Crossref","is-referenced-by-count":23,"title":["Mexico's precursor chemical controls: Emergence of less potent types of methamphetamine in the United States"],"prefix":"10.1016","volume":"129","author":[{"given":"James K.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane Carlisle","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio","family":"Campollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon-Mu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Lattyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell C.","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0005","doi-asserted-by":"crossref","unstructured":"Arkes, J., Pacula, R.L., Paddock, S.M., Caulkins, J.P., Reuter, P., 2008. Why the DEA STRIDE Data are Still Useful for Understanding Drug Markets. Working Paper 14224. National Bureau of Economic Research, Cambridge, MA.","DOI":"10.3386\/w14224"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/01621459.1975.10480264","article-title":"Intervention analysis with applications to economic and environmental problems","volume":"70","author":"Box","year":"1975","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/10826080500411478","article-title":"Trends in production, trafficking and consumption of methamphetamine and cocaine in Mexico","volume":"41","author":"Brouwer","year":"2006","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0020","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/0269881110378370","article-title":"Instability of the ecstasy market and a new kid on the block: mephedrone","volume":"25","author":"Brunt","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugpo.2011.05.016","article-title":"Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands","volume":"23","author":"Brunt","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.drugalcdep.2009.06.024","article-title":"Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions","volume":"105","author":"Callaghan","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/01621459.1993.10594321","article-title":"Joint estimation of model parameters and outlier effects in time series","volume":"88","author":"Chen","year":"1993","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jat\/17.6.321","article-title":"Interpretation of methamphetamine and amphetamine enantiomer data","volume":"17","author":"Cody","year":"1993","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0045","series-title":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios. Convenio de Concertaci\u00f3n de Acciones para un Efectivo Control de Medicamentos que Contienen Pseudoefedrina","author":"COFEPRIS","year":"2006"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0050","series-title":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios. Control de la Pseudoefedrina en M\u00e9xico","author":"COFEPRIS","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0055","series-title":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios. La COFEPRIS Present\u00f3 ante la PGR 41 Denuncias Penales por 161 Permisos Sanitarios de Importaci\u00f3n Ap\u00f3crifos","author":"COFEPRIS","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0060","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.291.17.2114","article-title":"Prevalence of marijuana use disorders in the United States, 1991\u20131992 and 2001\u20132002","volume":"291","author":"Compton","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0065","first-page":"31","article-title":"Acuerdo por el que se establecen medidas de protecci\u00f3n en material de salud humana para prevenir el uso y consumo de pseudoefedrina y efedrina.","volume":"2008","author":"Consejo de Salubridad General","year":"2008","journal-title":"Diario Oficial viernes 13 de junio de"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0070","series-title":"Quasi-Experimentation Design and Analysis Issues for Field Settings.","author":"Cook","year":"1979"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0075","series-title":"Entrevista al Secretario de Salud, Jos\u00e9 \u00c1ngel C\u00f3rdova Villalobos, al Termino de XXII Congreso Internacional de Farmacias.","author":"Cordova Villalobos","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0080","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1360-0443.2010.03068.x","article-title":"Mexico's methamphetamine precursor chemical interventions: impacts on methamphetamine treatment admissions","volume":"105","author":"Cunningham","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2012.04.011","article-title":"Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures","volume":"126","author":"Cunningham","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1360-0443.2003.00450.x","article-title":"Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine related hospital admissions","volume":"98","author":"Cunningham","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1360-0443.2005.01032.x","article-title":"Impacts of federal precursor chemical regulations on methamphetamine arrests","volume":"100","author":"Cunningham","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0100","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.socscimed.2007.12.006","article-title":"Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment","volume":"66","author":"Cunningham","year":"2008","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1360-0443.2008.02458.x","article-title":"Impact of US and Canadian precursor regulation on methamphetamine purity in the United States","volume":"104","author":"Cunningham","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1360-0443.2008.02208.x","article-title":"Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting","volume":"103","author":"Cunningham","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1360-0443.2010.03032.x","article-title":"Proximity to the US\u2013Mexico border: a key to explaining geographic variation in US methamphetamine, cocaine, and heroin purity","volume":"105","author":"Cunningham","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jhealeco.2005.08.003","article-title":"The effects of cocaine and heroin price on drug-related emergency department visits","volume":"25","author":"Dave","year":"2006","journal-title":"J. Health Econ."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0125","series-title":"Drug Enforcement Administration. Methamphetamine Profiling Program January 2005","author":"DEA","year":"2005"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0130","series-title":"Drug Enforcement Administration. Methamphetamine Profiling Program January 2011","author":"DEA","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0135","series-title":"Drug Enforcement Administration. Methamphetamine Profiling Program April 2012","author":"DEA","year":"2012"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ei\/41.1.98","article-title":"Price and enforcement effects on cocaine and marijuana demand","volume":"41","author":"DeSimone","year":"2003","journal-title":"Econ. Inq."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0145","series-title":"European Monitoring Centre for Drugs and Drug Addiction. EMCDDA Insights\u2014Prevention of Substance Abuse","author":"EMCDDA","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0150","first-page":"21","article-title":"Pseudoefedrina: se proh\u00edbe su comercializaci\u00f3n en M\u00e9xico","volume":"11","author":"F\u00e1rmacos","year":"2008","journal-title":"F\u00e1rmacos"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0155","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2967\/jnumed.107.040279","article-title":"PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and (\u2212)-cocaine","volume":"48","author":"Fowler","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0160","doi-asserted-by":"crossref","unstructured":"Grossman, M., Chaloupka, F.J., Brown, C.C., 1996. The Demand for Cocaine by Young Adults: A Rational Addiction Approach. Working Paper 5713. National Bureau of Economic Research, Cambridge, MA.","DOI":"10.3386\/w5713"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1198\/016214501753381904","article-title":"Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs?","volume":"96","author":"Horowitz","year":"2001","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0170","unstructured":"INCB, 2006. International Narcotics Control Board. Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances. Report of the International Narcotics Control Board for 2005. United Nations, New York."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0175","unstructured":"INCB, 2007. International Narcotics Control Board. Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances. Report of the International Narcotics Control Board for 2006. United Nations, New York."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0180","unstructured":"INCB, 2008. International Narcotics Control Board. Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances. Report of the International Narcotics Control Board for 2007. United Nations, New York."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0185","unstructured":"INCB, 2011. International Narcotics Control Board. Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances. Report of the International Narcotics Control Board for 2010. United Nations, New York."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0190","unstructured":"INCB, 2012. International Narcotics Control Board. Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances. Report of the International Narcotics Control Board for 2011. United Nations, New York."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0195","series-title":"Time Series Analysis and Forecasting","author":"Liu","year":"2006"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0200","first-page":"1217","article-title":"Recent developments of time series analysis in intervention and environmental impact studies","volume":"A26","author":"Liu","year":"1991","journal-title":"J. Environ. Sci. Health"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0205","series-title":"New and Enhanced Capabilities in Release 8 of the SCA Statistical System","author":"Liu","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0210","series-title":"Informing America's Policy on Illegal Drugs: What We Don\u2019t Know Keeps Hurting Us. National Research Council","author":"Manski","year":"2001"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0215","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.addbeh.2011.07.017","article-title":"Methamphetamine: here we go again?","volume":"36","author":"Maxwell","year":"2011","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0220","unstructured":"McCampbell, C.A., 2007. Statement by Christy A. McCampbell, Deputy Assistant Secretary, Bureau for International Narcotics and Law Enforcement Affairs, U.S. Department of State. Testimony before the Senate Finance Committee September 18, 2007. Bilateral and multilateral efforts to combat the international production and trafficking of methamphetamine. U.S. Government Printing Office, Washington, DC, pp. 86\u201395."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0225","series-title":"Applied Time Series Analysis for the Social Sciences","author":"McCleary","year":"1980"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0230","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1360-0443.2011.03582.x","article-title":"A systematic review of methamphetamine precursor regulations","volume":"106","author":"McKetin","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clpt.2006.06.013","article-title":"Human pharmacology of the methamphetamine stereoisomers","volume":"80","author":"Mendelson","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0240","series-title":"National Drug Intelligence Center. National Drug Threat Assessment 2009","author":"NDIC","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0245","series-title":"National Drug Intelligence Center. National Drug Threat Assessment 2010","author":"NDIC","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0250","series-title":"National Drug Intelligence Center. National Drug Threat Assessment 2011","author":"NDIC","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0255","author":"PGR","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","article-title":"Risk environments and drug harms: a social science for harm reduction approach","volume":"20","author":"Rhodes","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0265","first-page":"1264","article-title":"Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? Comment","volume":"96","author":"Rhodes","year":"2001","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0270","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09595230600944529","article-title":"A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs","volume":"25","author":"Ritter","year":"2006","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0275","series-title":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS) 2000\u20132010","author":"SAMHSA","year":"2012"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0280","author":"SFP","year":"2006"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0285","series-title":"Experimental and Quasi-experimental Designs for Generalized Causal Inference","author":"Shadish","year":"2002"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0290","doi-asserted-by":"crossref","unstructured":"Tsujikawa, K., Kuwayama, K., Miyaguchi, H., Kanamori, T., Iwata, Y.T., Inoue, H., 2012. Chemical profiling of seized methamphetamine putatively synthesized from phenylacetic acid derivatives. Forensic Sci. Int. Available at: http:\/\/dx.doi.org\/10.1016\/j.forsciint.2012.08.036.","DOI":"10.1016\/j.forsciint.2012.08.036"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0295","series-title":"United Nations Office on Drugs and Crime. 2008 World Drug Report","author":"UNODC","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0300","series-title":"United Nations Office on Drugs and Crime. Amphetamines and Ecstasy. 2011 Global ATS Assessment","author":"UNODC","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.10.001_bib0305","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/09595230801956140","article-title":"Patterns of benzylpiperazine\/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand","volume":"27","author":"Wilkins","year":"2008","journal-title":"Drug Alcohol Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612003961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612003961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T01:06:57Z","timestamp":1714525617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612003961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":61,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0376871612003961"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.10.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}